NEAT1 and plasma cell myeloma: In fact, the follow-up of this work will be aimed at the pharmacological disruption of NEAT1 binding using RNA-mimetics, which are able to selectively bind to NONO and/or SFPQ RNA-recognition site, impairing paraspeckle formation, thus being a first step towards the rational design of new drugs for the treatment of multiple myeloma.